Clinical trial
Randomised Prospective Multicenter Longterm-Evaluation of the Survival Rate of the Implant, Wear and Periprosthetic Osteolysis of Highly Cross-linked Polyethylene With and Without Addition of Vitamin E (UHMWPE-XE vs. UHMWPE-X)
NCT01713062 is registered in ClinicalTrials.gov with Aesculap AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Prospective Multicenter Longterm-Evaluation of the Survival Rate of the Implant, Wear and Periprosthetic Osteolysis of Highly Cross-linked Polyethylene With and Without Addition of Vitamin E (UHMWPE-XE vs. UHMWPE-X)
- Lead sponsor
- Aesculap AG
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 31, 2012
- Completion date
- June 30, 2030
- Enrollment
- 400 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.